Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment

Acta Ophthalmologica

Volumn 88, Issue 6, 2010, Pages 635-640

  Yeung, Ling ^a,b   Liu, Laura ^a,b   Wu, Wei Chi ^a,b   Kuo, Ya Hui ^a,b   Chao, An Ning ^a,b   Chen, Kuan Jen ^a,b   Yang, Ko Jen ^a,b   Chen, Tun Lu ^a,b   Lai, Chi Chun ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

bevacizumab; postoperative vitreous haemorrhage; proliferative diabetic retinopathy; tractional retinal detachment

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; ENDOPHTHALMITIS; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FLUOROCARBONS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 77956214919     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01498.x     Document Type: Article

References (32)

1. Aiello LP, Brucker AJ, Chang S et al. (2004 Evolving guidelines for intravitreous injections. Retina 24 3 19.
2. Algvere PV, Kvanta A Seregard S (2008 Shall we use Avastin or Lucentis for ocular neovascularization? Acta Ophthalmol 86 : 352 355.
3. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H et al. (2007 Primary intravitreal bevacizumab (Avastin) for diabetic macular oedema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114 : 743 750.
4. Arevalo JF, Wu L, Sanchez JG, Maia M, Saravia MJ, Fernandez CF Evans T (2009 Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye 23 : 117 123.
5. Avery RL, Pearlman J, Pieramici DJ et al. (2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 : 1695.
6. Bakri SJ, Snyder MR, Reid JM, Pulido JS Singh RJ (2007 Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114 : 855 859.
7. de Bustros S, Glaser BM, Michels RG Auer C (1985 Effect of epsilon-aminocaproic acid on post-vitrectomy haemorrhage. Arch Ophthalmol 103 : 219 221.
8. Chen E Park CH (2006 Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 26 : 699 700.
9. Dafer RM, Schneck M, Friberg TR Jay WM (2007 Intravitreal ranibizumab and bevacizumab: a review of risk. Semin Ophthalmol 22 : 201 204.
10. Grigorian RA, Castellarin A, Fegan R, Seery C, Del Priore LV, Von HS Zarbin MA (2003 Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling. Br J Ophthalmol 87 : 737 741.
11. Haritoglou C, Kook D, Neubauer A et al. (2006 Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular oedema. Retina 26 : 999 1005.
12. Ishikawa K, Honda S, Tsukahara Y Negi A (2009 Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye 23 : 108 111.
13. Jonas JB, Libondi T, von BS Vossmerbaeumer U (2008 Intravitreal bevacizumab for vitreous haemorrhage. Acta Ophthalmol 86 : 585 586.
14. Joondeph BC Blankenship GW (1989 Haemostatic effects of air versus fluid in diabetic vitrectomy. Ophthalmology 96 : 1701 1706.
15. Jorge R, Costa RA, Calucci D, Cintra LP Scott IU (2006 Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study). Retina 26 : 1006 1013.
16. Koutsandrea CN, Apostolopoulos MN, Chatzoulis DZ, Parikakis EA Theodossiadis GP (2001 Haemostatic effects of SF6 after diabetic vitrectomy for vitreous haemorrhage. Acta Ophthalmol Scand 79 : 34 38.
17. Lee CS Koh HJ (2008 Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin®) with pars plana vitrectomy. Acta Ophthalmol 86 : 812 813.
18. Minnella AM, Savastano CM, Ziccardi L, Scupola A, Sasso P, Falsini B Balestrazzi E (2008 Intravitreal bevacizumab (Avastin®) in proliferative diabetic retinopathy. Acta Ophthalmol 86 : 683 687.
19. Novak MA, Rice TA, Michels RG Auer C (1984 Vitreous haemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 91 : 1485 1489.
20. Oshima Y, Sakaguchi H, Gomi F Tano Y (2006 Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 142 : 155 158.
21. Quiroz-Mercado H, Ustariz-Gonzalez O, Martinez-Castellanos MA, Covarrubias P, Dominguez F Sanchez-Huerta V (2007 Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story. Semin Ophthalmol 22 : 109 125.
22. Ramezani AR, Ahmadieh H, Ghaseminejad AK, Yazdani S Golestan B (2005 Effect of tranexamic acid on early post-vitrectomy diabetic haemorrhage: a randomized clinical trial. Br J Ophthalmol 89 : 1041 1044.
23. Rizzo S, Genovesi-Ebert F, Di BE, Vento A, Miniaci S Williams G (2008 Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 246 : 837 842.
24. Ruiz-Moreno JM, Montero JA, Lugo F, Amat P Staicu C (2008 Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy. Acta Ophthalmol 86 : 231 232.
25. Sawada O, Kawamura H, Kakinoki M, Sawada T Ohji M (2007 Vascular endothelial growth factor in aqueous humour before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy. Arch Ophthalmol 125 : 1363 1366.
26. Schachat AP, Oyakawa RT, Michels RG Rice TA (1983 Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 90 : 522 530.
27. Scott IU, Schein OD, West S, Bandeen-Roche K, Enger C Folstein MF (1994 Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol 112 : 329 335.
28. Shima C, Sakaguchi H, Gomi F et al. (2008 Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86 : 372 376.
29. Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS Larsen M (2008 Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 365 371.
30. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU Jorge R (2008 Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86 : 385 389.
31. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H et al. (2008 Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246 : 81 87.
32. Yang CM, Yeh PT Yang CH (2007 Intravitreal long-acting gas in the prevention of early postoperative vitreous haemorrhage in diabetic vitrectomy. Ophthalmology 114 : 710 715.